<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Verona Pharma plc

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Verona Pharma plc

    Verona Pharma plc is a clinical stage biopharmaceutical company focused on the development and commercialization of innovative prescription medicines to treat respiratory diseases with significant unmet medical needs, such as COPD, cystic fibrosis and asthma. The Company is listed on the Nasdaq Global Market in the United States under the VRNA ticker and on the London Stock Exchange in the United Kingdom under the VRP.L ticker. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Jan-Anders Karlsson Ph.D
    • FOUNDED
      2005
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    ProLung, Inc.

    ProLung, Inc.

    ProLung is a medical technology company specializing in innovative predictive anal...

    ProLung is a medical technology company special...

    Filing Type:    PU
    Mighty Health Co.

    Mighty Health Co.

    It was the middle of 2016 when we discovered that CBD could make a big difference ...

    It was the middle of 2016 when we discovered th...

    Fundraising Status:    EC
    Filing Type:    CF
    Alimera Sciences, Inc.

    Alimera Sciences, Inc.

    Alimera Sciences (NASDAQ: ALIM), founded in June 2003, is a pharmaceutical company...

    Alimera Sciences (NASDAQ: ALIM), founded in Jun...

    Filing Type:    PU
    NGM Biopharmaceuticals, Inc.

    NGM Biopharmaceuticals, Inc.

    We are a clinical stage biopharmaceutical company focused on harnessing powerful b...

    We are a clinical stage biopharmaceutical compa...

    Filing Type:    PU
    Acasti Pharma, Inc.

    Acasti Pharma, Inc.

    Acasti is a biopharmaceutical innovator focused on the research, development and c...

    Acasti is a biopharmaceutical innovator focused...

    Filing Type:    PU
    Seattle Genetics, Inc.

    Seattle Genetics, Inc.

    Founded 20 years ago, Seattle Genetics was built on a foundation of scientific inn...

    Founded 20 years ago, Seattle Genetics was buil...

    Filing Type:    PU
    Innoviva, Inc.

    Innoviva, Inc.

    Innoviva, Inc. (NASDAQ: INVA) is focused on royalty management. Innoviva’s portf...

    Innoviva, Inc. (NASDAQ: INVA) is focused on roy...

    Filing Type:    PU
    Itamar Medical Ltd.

    Itamar Medical Ltd.

    Itamar Medical Ltd. is a publicly traded medical device company (TASE:ITMR) based ...

    Itamar Medical Ltd. is a publicly traded medica...

    Filing Type:    PU
    MediciNova, Inc.

    MediciNova, Inc.

    MediciNova, Inc. is a publicly-traded biopharmaceutical company focused on acquiri...

    MediciNova, Inc. is a publicly-traded biopharma...

    Filing Type:    PU
    Regeneron Pharmaceuticals, Inc.

    Regeneron Pharmaceuticals, Inc.

    We are a leading science and technology company that delivers life-transforming me...

    We are a leading science and technology company...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.